Clinical Trials Browser

Phase 1/2 × Terminated × Idarubicin × Clear all

NCT01876953 2022-03-31

Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia

Phase 1/2 Terminated

20 enrolled 9 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Myeloid, Acute

NCT02440568 2021-07-06

AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients

Phase 1/2 Terminated

22 enrolled 17 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute